About this trial
Our main objective is to analyze the development of physical impact, mental health and blood profile over follow-up time during the 1st wave of the COVID-19. Besides, we aim to establish a database of post-COVID-19 based on simultaneous cortico-spinal magnetic resonance imaging data to identify high-risk patients with long COVID and prevent the neurological symptoms evolution, optimize the tactics of management in China.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- Simultaneous cortico-spinal magnetic resonance imaging, Serum
Treatment groups
Sponsors and collaborators
First Affiliated Hospital Xi'an Jiaotong University
Lead sponsor
Nuclear 215 Hospital of Shaanxi Province
Collaborator
Yanan Traditional Chinese Medicine Hospital
Collaborator
Shangluo Central Hospital
Collaborator
Xian QinHuang Hospital
Collaborator
Yulin No.2 Hospital
Collaborator
Hanzhong Central Hospital
Collaborator
Ankang Central Hospital
Collaborator
Baoji High-tech Hospital
Collaborator